Capnopharm GmbH

medical devices

About

Capnopharm develops aerosol-based chemotherapies and immunotherapies for peritoneal and pleural cancer patients. Our science relies on a growing body of evidence around PIPAC (Pressurized Intraperitoneal Aerosol Chemotherapy), a minimally invasive aerosol drug delivery system. PIPAC provides numerous avenues for research and development in oncology – from re-formulation of existing chemotherapy drugs to next-generation drugs involving Nanoparticles, DNA, mRNA or Immunotherapeutics. Together with our pharmaceutical clients, we explore drug-device synergies which could shape the future of cancer care. In doing so, we are devoted to our mission of improving the health and well-being of cancer patients around the world, for the best possible quality of life.

Technologies

OutlookWordPress.orgApacheMobile Friendly

Keywords

medical devicesoncologypipacperitoneal cancercancerimmunotherapysurgical oncologyintraperitoneal chemotherapymedtechcapnopenmedical equipment manufacturingmedical equipment and supplies manufacturinginnovative cancer treatmentsoncology researchoff-label drug deliveryregulatory certificationnanoparticlestranslational researchmedical technologydrug-device synergymedical device developmentcancer therapyb2cpersonalized medicinebiotech awardspipac ecosystemmrnagerman medical awardregulatory approvalmedical device certification

Location

17 Vor dem Kreuzberg, Tuebingen, Baden-Wuerttemberg, Germany, 72070

Related Companies

Companies in the same industry